Individual Variation in DNA Repair in Human Peripheral Blood Monocytes

  • Robert S. Lake
Part of the Environmental Science Research book series (ESRH, volume 30)


The growing list of genetic and biological markers presently applied for predicting risk of human beings to manifest irreversible chemically induced disease is now legion. It includes at the cellular level such diverse endpoints as cytogenetics [1], mutagen/carcinogen metabolism, DNA damage and repair [2, 3], mutability, transformability [4], promotability, radiosensitivity, immunokinetics, and cell physiology. Yet, the list of suitable and accessible human tissues available is small, limited in practice to heterogeneous cultured skin cells of fibroblastic or epithelial morphology, peripheral blood lymphocytes [5], bone marrow, and organ autopsy or biopsy specimens. Each cell system has a common limitation in that baseline parameters which may not be stable or intrinsic are measured after some intervening culture manipulation. To circumvent this limitation, the studies to be discussed in this presentation have focused on the peripheral blood monocyte as a potential fresh ex vivo cell type in which to study selected endpoints [6, 7, 8]. Specifically, the extent of benzo[a]pyrene metabolism and unscheduled DNA synthesis after several DNA damaging treatments have been examined. These studies have lead to the realization that in vitro individuality in response to genetic damage is a complex function of both extra-genetic response to the agent(s) inflicting damage and possible genetically based peculiarities in processing of resultant lesions.


Blood Monocyte Peripheral Blood Monocyte Genetic Damage Human Peripheral Blood Monocyte Amino Fluorene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    C. F. Arlett and A. R. Lehmann, Human disorders showing increased sensitivity to the induction of genetic damage, Ann. Rev. Genet., 12:95–115 (1978).CrossRefGoogle Scholar
  2. 2.
    R. T. Barfknecht and J. B. Little, Abnormal sensitivity of skin fibroblasts from familial polyposis patients to DNA alkylating agents, Cancer Res., 42: 1249–1254 (1982).Google Scholar
  3. 3.
    N. G. J. Jaspers, J. de Wit, M. R. Regulski, and D. Bootsma, Abnormal regulation of DNA replication and increased lethality in Ataxia Telangiectasia cells exposed to carcinogenic agents, Cancer Res., 42: 335–341 (1982).Google Scholar
  4. 4.
    T. Kakunaga and J. D. Crow, Cell variants showing differential susceptibility to ultraviolet light-induced transformation, Science, 209: 505–507 (1980).ADSCrossRefGoogle Scholar
  5. 5.
    R. W. Pero and C. Ostlund, Direct comparison, in human resting lymphocytes, of the interindividual variations in unscheduled DNA synthesis induced by N-acetoxy-2-acetylamino fluorene and ultraviolet irradiation, Mut. Res., 73: 349–361 (1980).CrossRefGoogle Scholar
  6. 6.
    R. S. Lake, M. R. Pezzutti, M. L. Kropko, A. E. Freeman, and H. J. Igel, Measurement of benzo[a]pyrene metabolism in human monocytes, Cancer Res., 37: 2530–2537 (1977).Google Scholar
  7. 7.
    R. S. Lake, M. L. Kropko, S. McLachlan, M. R. Pezzutti, R. H. Shoemaker, and H. J. Igel, Chemical carcinogen induction of DNA-repair synthesis in human peripheral blood monocytes, Mut. Res., 74: 357–377 (1980).Google Scholar
  8. 8.
    M. W. Kahng, M. W. Smith, and B. F. Trump, Aryl hydrocarbon hydroxylase in human bronchial epithelium and blood monocyte, J. Natl. Cancer Inst., 66: 227–232 (1981).Google Scholar
  9. 9.
    R. W. Pero and C. Vopat, A human platelet-derived inhibitor of unscheduled DNA synthesis in resting lymphocytes, Carcinogenesis, 2: 1103–1110 (1981).CrossRefGoogle Scholar
  10. 10.
    A. Volkman, in: Immunobiology of the Macrophage ( D. S. Nelson, ed.), pp. 291–322, Academic Press, New York (1976).Google Scholar
  11. 11.
    R. W. Pero and H. O. Sjogren, The influence of monocyte (adherent cell) content in human mononuclear blood populations on the estimation of individual levels of N-acetoxy-2-acetyl-aminofluorene induced unscheduled DNA synthesis, Carcinogenesis, 3: 39–43 (1982).CrossRefGoogle Scholar
  12. 12.
    G. M. Williams, Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures, Cancer Res., 37: 1845–1851 (1977).Google Scholar
  13. 13.
    C. J. Skidmore, M. I. Davies, P. M. Goodwin, 0. Omidiji, A. Zia’ee, and S. Shall, in: Novel ADP–Ribosylations of Regulatory Enzymes and Proteins (Smulson and Sugimura, eds.), pp. 197–205, Elsevier North Holland, Inc., Amsterdam (1980).Google Scholar
  14. 14.
    K. W. Kohn and R. A. Grimek-Ewig, Alkaline elution analysis, a new approach to the study of DNA single-strand interruptions in cells, Cancer Res., 33: 1849–1853 (1973).Google Scholar
  15. 15.
    H. C. Birnboim and J. J. Jevcak, Fluorometric method for rapid detection of DNA strand breaks in human blood cells produced by low doses of radiation, Cancer Res., 41:1889–1892 (1981).Google Scholar
  16. 16.
    E. S. Vesell, Intraspecies differences in frequency of genes directly affecting drug disposition: the individual factor in drug response, Pharm. Revs., 30:555–563 (1978).Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Robert S. Lake
    • 1
  1. 1.Pathology-Toxicology Pharmaceutical Research DivisionSchering-Plough CorporationLafayetteUSA

Personalised recommendations